GUIA DE SEGUIMIENTO FARMACOTERAPEUTICO SOBRE DIABETES PDF

que la mortalidad a largo plazo esté relacionada sobre todo con la recidiva de la enfermedad actuaciones en una guía de seguimiento del paciente trasplantado. . documento recoge recomendaciones farmacoterapéuticas, de autocuidado, de . de las guías. • Algunos pacientes pueden comenzar con una diabetes de. Efectividad del seguimiento farmacoterapéutico en diabéticos tipo 2 clínica, se obtuvo información sobre medicamentos antidiabéticos utilizados, dosis, .. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. Objetivos: Realizar un seguimiento farmacoterapéutico y educar a pacientes conocimiento sobre la menopausia y la THR en pacientes menopaúsicas. Keywords: Hormone . ministerial que generará Guías Clínicas y tratará . stock de éste por el laboratorio que los produce. Diabetes. 38%. Depresión.

Author: Malarisar JoJolrajas
Country: Zimbabwe
Language: English (Spanish)
Genre: History
Published (Last): 5 June 2004
Pages: 69
PDF File Size: 9.63 Mb
ePub File Size: 18.51 Mb
ISBN: 825-6-40343-216-5
Downloads: 8754
Price: Free* [*Free Regsitration Required]
Uploader: Tutaxe

This study did not reveal increased effectiveness in treatment of patients with type-2 diabetes mellitus, which also occurred in the study by Beney et al. Guide to drug dosage in renal failure. The distribution of the different study and sociodemographic variables can be seen in Table 1.

On farmacotetapeutico other hand, hypertension and DM are the most important risk guiw that lead to deterioration in renal function, because the kidney is one of famracoterapeutico target organs in these conditions; at the same time, together they will increase the cardiovascular risk 22 Of these 6 non-accepted interventions, 3 health problems were not solved, 12 dose readjustments were conducted, with cefepime as the drug with the highest number of dose adjustments; most patients were in Stage III and V of CKD, and its main cause was hypertension and Diabetes Mellitus II.

Very frequently, the medical histories do not contain sufficient and necessary diabstes for the case analysis in pharmacotherapeutical monitoring, given that many patients are seen by hired specialists, who generate reports different from those in the medical chart at the EPS, and access to this information is difficult in spite of multiple requests.

Effectiveness the pharmaceutical care in diabetic patients* | Machado -Alba | Colombia Médica

On the other hand, there was an increase in the haemoglobin levels in the optimal group. The impact of chronic kidney disease in health is no longer just a patient-physician issue, not only in terms of the increase in the number of patients diagnosed, but also regarding the human and economic cost for health farjacoterapeutico.

Initial HbA1c mean was 7. The medications with one single case were clobazam, ceftriaxone and dexamethasone.

The Ethics Committee of the centre approved the study. Negative outcomes associated with medication.

Universidad de Granada Grupo de Investigación en Atención Farmacéutica

In total, 12 dose re-adjustments were conducted, and 10 of these were accepted. Along with other studies, during the initial interview, we found co-morbidities seguimientk associated to diabetes, such as hypertension Poor control of patients with type-2 diabetes mellitus is a problem affecting all nations.

  APPUNTI DI ESTIMO PER GEOMETRI PDF

The most frequent NOM causes in these four pharmacological groups were thus: Expanding the roles of outpatient pharmacists: The farmaciterapeutico analysis revealed the following: Statistical Analysis The outcomes of the pharmaceutical interventions in the study were statistically analyzed with the STATA program version Mean age was Besides, in our study, there were more reports for Quantitative Ineffectiveness; the reason for this was the lack of modification in treatment dosing, even when this was allowed by the therapeutic window of drugs.

Ars Pharm ; 48 1: During the initial and final visits for the intervention group, the intervention was accepted and the health problem was solved in 72 cases Only 39 patients Conclusion The NOMs with the highest prevalence were those for Non-Quantitative Insecurity; therefore, these represent a highly prevalent problem. The likelihood of adverse effects was the main reason for NOM presentation. Finally, it must be stated that the results are only applicable to populations of diabetic patients with similar characteristics who are affiliated to the contributive healthcare regime of Colombia’s General System of Health and Social Security.

Necessity NOMs showed that not all the health problems are being treated in these patients; that is to say, only their basal disease was controlled, while the problems caused by it were being overlooked.

Adis Internacional Limited, This shows that the work by the Pharmacist is as important as that of any other health professional; they will not only be in charge of the adequate storage and preparation of medications, but will also contribute to meeting their target objectives with the lowest risk possible, as described by Ohnishi et al.

Universidad de Granada; The study had a sample of patients 64 intervened and 79 controls with female predominance The loss of According to studies, Clinical Pharmacy has ensured an increase in the knowledge of medications by patients, a reduction in hospitalization rate, and an improvement in their quality of life 18 Los pacientes de ambos grupos tomaban en promedio 6.

The sample size was estimated as the comparison of two proportions. The researchers could not guarantee that the written reports with the intervention recommendations made by a pharmacist reached the treating physician; thus, the suggested intervention would or would not be accepted upon the detection of an NOM.

Because the statistics for farmacoterapeutoco tests were not significant, we opted for a bivariate analysis for the quantitative parameters via hazard ratios. Rev Asoc Latinoam Diabetes.

Seguimiento farmacoterapéutico en pacientes con insuficiencia renal crónica

Like a snake in the grass. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Causes of NOM identified in the study patients can be seen in Table 3. Discussion There was no significant difference found in CKD patients regarding gender; that is to say, male patients are at the farmacoteapeutico risk of developing it as female patients.

  DERECH TEVUNOT PDF

Due to the reduction in the glomerular filtration rate, the excretory and waste depurative function is reduced; this situation can affect the drug kinetics and dynamics, and this can have an impact on pharmacological treatment, an increase farmacotdrapeutico the intensity and therapeutic effect, such as adverse events There no important variations or statistically significant differences in HbA1c values for patients in the intervention and control groups at the end sgeuimiento the study; although there was a reduction in values segui,iento glycated hemoglobin in the intervention group, making it convenient to suggest a similar study with a bigger population sample and a better control of losses.

The status of the condition was elaborated including diagnosis, each of the medications being taken, doses and dose intervals.

To reduce health complications and costs in healthcare systems, strategies have been sought to contribute to such aims and which directly involve the pharmacist through a pharmaceutical care program, developed by Hepler and Strand in 8 ; its objective is the optimization of the clinical results of the drug therapy, improvement of patient quality of life, contribution to the rational use of medications, and detection, prevention, and solution to Negative Outcomes Associated with Medication NOM 9 Inf Ter Nac Salud.

Universidad de Deusto; Patients changing EPS during the study; those whose physical or mental state did not permit communicating with the interviewer; and patients who did not remain in the city selected for the study during the time it took to develop such.

It was noted that the mean ratio average per patient for the patients in the control group was 1. Each of the patients had a replacement selected randomly and with the same characteristics.

A guidance statement from the American College of Physicians. Additionally, we sought to determine the costs of caring for these patients during the study period.

There is evidence in different countries around the world that the lack of Farmadoterapeutico detection and solution may lead to additional costs in the healthcare system.

El cociente medio del costo por paciente en el grupo control fue 1.

Author: admin